Avanza Fonder Ab Exact Sciences Corp Transaction History
Avanza Fonder Ab
- $3.37 Trillion
- Q4 2024
A detailed history of Avanza Fonder Ab transactions in Exact Sciences Corp stock. As of the latest transaction made, Avanza Fonder Ab holds 19,512 shares of EXAS stock, worth $984,185. This represents 0.03% of its overall portfolio holdings.
Number of Shares
19,512Holding current value
$984,185% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
674Shares Held
162MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$896 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$799 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$723 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$609 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$337 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.93B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...